Spotlight: James Wall, MD

A surgeon, an educator and a physician entrepreneur, James Wall, MD, has already accomplished more than most in his budding career. Recently named co-director of Stanford Biodesign’s Innovation Fellowship, he is an assistant professor of surgery at Stanford University where he focuses on minimally invasive approaches to children’s surgery. He has developed multiple medical devices,

Enspectra Receives Series A Funding; Moves Forward in Widening Market for Skin Cancer Detection Breakthrough

Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan Ventures, a technology-focused venture fund based in Los Altos, Calif.

Funding success will serve several needs

“Fundraising has been one of our major focuses as we seek to take the startup to the next level,” said Gabriel Sanchez,

Fogarty Institute Startups Make Strides; Raise Funds

It’s often said that the only constant is change. Here at the Fogarty Institute, we embrace that sentiment because in the world of medtech, change is inevitable to continue to enhance patient care. That’s why we are delighted with recent advances in funding – while the funding environment can be challenging, the industry has demonstrated resilience and agility as startups seek to get innovative devices to market.

Mobile Makerspace Concept for Hospitalized, Chronically Ill Patients Is Officially On the Move

What started as a vision to use a mobile makerspace as a tool to inspire young, chronically ill patients to learn, create and innovate – and help make lengthy hospital stays more palatable – is now becoming a reality, thanks to the generous support of Sheri Sobrato Brisson, a long-time supporter of seriously and chronically ill children,

Healyx Changes Lives by Treating Chronic Wounds

Lower-cost, more-effective treatments are the hallmark of many Fogarty Institute companies, and that is the principle Healyx is living up to with its device that provides gold standard care for a chronic problem at a significant cost reduction.

Non-healing wounds are a critical global issue, with over eight million Medicare patients afflicted at an annual cost of $31.7 billion in the U.S.

Q&A With Holly Rockweiler, CEO and Co-Founder of Madorra

A former Stanford Biodesign Fellow and Fogarty Institute entrepreneur, 32-year-old Holly Rockweiler has already had remarkable accomplishments early in her career, fluently moving her startup to the next level.

Most notably, Holly has parlayed Madorra’s impressive study results into securing funding, including winning several pitching competitions, despite the chronically challenging medtech fundraising environment.

New Fogarty Institute Company Lume Medical Developing a Large Bore Vascular Closure Device, a Key Benefit to Cardio Patients

When a cardiovascular intervention is called for, a less-invasive solution is always preferred – which is why percutaneous procedures, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR) are on the rise.

But this trend hasn’t been without its drawbacks, as cardiologists and surgeons are now faced with the challenge of closing relatively large femoral access sites – ranging from three to eight millimeters in size – that are required to conduct these procedures.

A Better Kind of “Gut Check”

Often referred to as the “second brain,” the gut is garnering increased attention as mounting evidence shows the key role it plays far beyond digesting food in influencing our moods and general health. G-Tech Medical, a Fogarty Institute company, is playing a critical role in helping to better understand the complexities of our gut and its 500 million neurons.

START TYPING AND PRESS ENTER TO SEARCH